Nutritional genetics: The case of alcohol and the MTHFR C677T polymorphism in relation to homocysteine in a black South African population

Journal of Nutrigenetics and Nutrigenomics

Volumn 6, Issue 2, 2013, Pages 61-72

  Nienaber Rousseau, Cornelie ^a   Pisa, Pedro T ^a   Venter, Christine S ^a   Ellis, Suria M ^a   Kruger, Annamarie ^a   Moss, Sarah J ^a   Melse Boonstra, Alida ^a,b   Towers, G Wayne ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Gamma glutamyltransferase; Nutritional genetics; Percentage carbohydrate deficient transferrin; Single nucleotide polymorphism; Total homocysteine

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOTIN; CARBOHYDRATE DEFICIENT TRANSFERRIN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; HOMOCYSTEINE; METHIONINE; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLACK PERSON; BLOOD SAMPLING; BODY MASS; COFFEE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRINKING; ENZYME BLOOD LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOOD FREQUENCY QUESTIONNAIRE; GENDER; GENE INTERACTION; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUTANT; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SELF REPORT; SOUTH AFRICAN; TEA; VITAMIN INTAKE; WILD TYPE;

EID: 84875640701     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000348839     Document Type: Article

References (52)

1. Parry CD, Plüddemann A, Steyn K, et al: Alcohol use in South Africa: findings from the first Demographic and Health Survey (1998). J Stud Alcohol 2005; 66: 91-97.
2. Agarwal DP: Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol 2002; 37: 409-415.
3. Bagnardi V, Zatonski W, Scotti L, et al: Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J Epidemiol Community Health 2008; 62: 615-619.
4. Puddey IB, Rakic V, Dimmitt SB, Beilin LJ: Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors -a review. Addiction 1999; 94: 649-663.
5. Corrao G, Bagnardi V, Zambon A, La Vecchia C: A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004; 38: 613-619.
6. Carmel R, James SJ: Alcohol abuse: an important cause of severe hyperhomocysteinemia. Nutr Rev 2002; 60: 215-221.
7. Castañon MM, Lauricella AM, Kordich L, Quintana I; Plasma homocysteine cutoff values for venous thrombosis. Clin Chem Lab Med 2007; 45: 232-236.
8. Humphrey LL, Fu R, Rogers K, et al: Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 2008; 83: 1203-1212.
9. Wu LL, Wu JT: Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 2002; 322: 21-28.
10. Bathum L, Petersen I, Christiansen L, et al: Genetic and environmental influences on plasma homocysteine: results from a Danish twin study. Clin Chem 2007; 53: 971-979.
11. De Bree A, Verschuren WM, Kromhout D, et al: Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 2002; 54: 599-618.
12. Waskiewicz A, Piotrowski W, Broda G, et al: Impact of MTHFR C677T gene polymorphism and vitamins intake on homocysteine concentration in the Polish adult population. Kardiol Pol 2011; 69: 1259-1264.
13. Barak AJ, Beckenhauer HC, Hidiroglou N, et al: The relationship of ethanol feeding to the methyl folate trap. Alcohol 1993; 10: 495-497.
14. Barak AJ, Beckenhauer HC, Kharbanda KK, et al: Chronic ethanol consumption increases homocysteine accumulation in hepatocytes. Alcohol 2001; 25: 77-81.
15. Teo K, Chow CK, Vaz M, et al: The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158: 1-7.e1.
16. Rasmussen K, Møller J: Methodologies of testing; in Carmel R, Jacobsen DW, (eds): Homocysteine in Health and Disease. Cambridge, Cambridge University Press, 2001, pp 199-211.
17. UNAIDS/WHO Policy Statement on HIV Testing. www.who.int/rpc/research-ethics/hivtestingpolicy-en-pdf. pdf. 3p. 2004.
18. Salaspuro M: Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol 1999;19: 261-271.
19. Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
20. MacIntyre UE, Venter CS, Vorster HH, Steyn HS: A combination of statistical methods for the analysis of the relative validation data of the quantitative food frequency questionnaire used in the THUSA study. Transition, Health and Urbanisation in South Africa. Public Health Nutr 2001; 4: 45-51.
21. Medical Research Council, Inc. FoodFinder 3 (food analysis software system, version 2. www.foodfinder3. co.za. 2007.
22. Langenhoven M, Kruger M, Gouws E (eds): Food composition tables. 3rd ed. Tygerberg, South African Medical Research Council Publishers, 1991, pp 1-227.
23. Statistica. StatSoft, Inc. STATISTICA (data analysis software system), version 8. www.statsoft.com. 2008.
24. Hardy GH: Mendelian proportions in a mixed population. Science 1908; 28: 49-50.
25. Walmsley CM, Bates CJ, Prentice A, Cole TJ: Relationship between alcohol and nutrient intakes and blood status indices of older people living in the UK: further analysis of data from the National Diet and Nutrition Survey of people aged 65 years and over, 1994/5. Public Health Nutr 1998; 1: 157-167.
26. Pisa PT, Kruger A, Vorster HH, et al: Alcohol consumption and cardiovascular disease risk in an African population in transition: the Prospective Urban and Rural Epidemiology (PURE) study. SA J Clin Nutr 2010; 23(suppl 1):S29-S37.
27. Loktionov A, Vorster H, O'Neill IK, et al: Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans. Atherosclerosis 1999; 145: 125-135.
28. Scholtz CL, Odendaal HJ, Thiart R, et al: Analysis of two mutations in the MTHFR gene associated with mild hyperhomocysteinaemia -heterogeneous distribution in the South African population. S Afr Med J 2002; 92: 464-467.
29. Conroy JM, Trivedi G, Sovd T, Caggana M: The allele frequency of mutations in four genes that confer enhanced susceptibility to venous thromboembolism in an unselected group of New York State newborns. Thromb Res 2000; 99: 317-324.
30. Guéant-Rodriguez RM, Guéant JL, Debard R, et al: Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 2006; 83: 701-707.
31. Kelemen LE, Anand SS, Hegele RA, et al: Associations of plasma homocysteine and the methylenetetrahydro-folate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis 2004; 176: 361-370.
32. Rady PL, Szucs S, Grady J, et al: Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002; 107: 162-168.
33. Adjalla CE, Amouzou EK, Sanni A, et al: Low frequency of mutated methylenetetrahydrofolate reductase 677C? T and 1298A? C genetics single nucleotide polymorphisms (SNPs) in Sub-Saharan populations. Clin Chem Lab Med 2003; 41: 1028-1032.
34. Anand SS, Yusuf S, Vuksan V, et al: Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356: 279-284.
35. Tavares EF, Vieira-Filho JP, Andriolo A, et al: Serum total homocysteine levels and the prevalence of folic acid deficiency and C677T mutation at the MTHFR gene in an indigenous population of Amazonia: the relationship of homocysteine with other cardiovascular risk factors. Ethn Dis 2004; 14: 49-56.
36. Eikelboom JW, Lonn E, Genest J Jr, et al: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-375.
37. Malinow MR, Bostom AG, Krauss RM: Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999; 99: 178-182.
38. Kang SS, Wong PW, Susmano A, et al: Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-545.
39. Andersson A, Brattström L, Israelsson B, et al: Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22: 79-87.
40. Brattström L, Lindgren A, Israelsson B, et al: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236: 633-641.
41. Giltay EJ, Hoogeveen EK, Elbers JM, Gooren, et al: Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab 1998; 83: 550-553.
42. Bates CJ, Mansoor MA, van der Pols J, et al: Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur J Clin Nutr 1997; 51: 691-697.
43. Selhub J, Jacques PF, Wilson PW, et al: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-2698.
44. Guttormsen AB, Ueland PM, Svarstad E, Refsum H: Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997; 52: 495-502.
45. Johnston DE: Special considerations in interpreting liver function tests. Am Fam Physician 1999; 59: 2223-2230.
46. Niemelä O: Biomarkers in alcoholism. Clin Chim Acta 2007; 377: 39-49.
47. Bleich S, Bleich K, Kropp S, et al: Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the 'French Paradox'? Alcohol Alcohol 2001; 36: 189-192.
48. Cravo ML, Glória LM, Selhub J, et al: Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr 1996; 63: 220-224.
49. Van der Gaag MS, Ubbink JB, Sillanaukee P, et al: Effect of consumption of red wine, spirits, and beer on serum homocysteine. Lancet 2000; 355: 1522.
50. Barak AJ, Beckenhauer HC, Junnila M, et al: Dietary betaine promotes generation of hepatic S-adenosylmethi-onine and protects the liver from ethanol-induced fatty infiltration. Alcohol Clin Exp Res 1993; 17: 552-555.
51. Shaw S, Jayatilleke E, Herbert V, Colman N: Cleavage of folates during ethanol metabolism. Role of acetal-dehyde/xanthine oxidase-generated superoxide. Biochem J 1989; 257: 277-280.
52. Hidiroglou N, Camilo ME, Beckenhauer HC, et al: Effect of chronic alcohol ingestion on hepatic folate distribution in the rat. Biochem Pharmacol 1994; 47: 1561-1566.